Skip to main content
Top

06-05-2024 | Obesity | REVIEW

Beyond Obesity and Overweight: The Clinical Assessment and Treatment of Excess Body Fat in Children

Part 1 — Insulin Resistance as the Root Cause of Pediatric Obesity

Authors: Mark Cucuzzella, James Bailes, Jenny Favret, Nina Paddu, Anna Beth Bradley

Published in: Current Obesity Reports

Login to get access

Abstract

Purpose of Review

Pediatric obesity and comorbidities related to insulin resistance continue to be a growing public health crisis. If lifestyle measures are unsuccessful, pharmacological and surgical interventions are offered. In this paper, we describe the driving force of the obesity crisis: hyperinsulinemia and the development of insulin resistance. We give historical background of key policy issues which have contributed to this pandemic as well as the physiologic mechanisms of insulin resistance. The prevalence of obesity will continue to rise unless the root cause of hyperinsulinemia is addressed.

Recent Findings

Current research on insulin resistance demonstrates that a decreased consumption of carbohydrates is an effective first-line dietary intervention for the treatment of obesity and related metabolic diseases. Evidence shows it is safe and beneficial.

Summary

A low-carbohydrate eating pattern can be helpful to address pediatric obesity. However, there must be policy guardrails in place to ensure that this is a sustainable and viable option for children and their families. There must be a change in the nutritional environment to help individuals battle the chronic disease of obesity.
Literature
3.
go back to reference •• Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060640. https://doi.org/10.1542/peds.2022-060640. The first edition of the American Academy of Pediatrics clinical practice guideline for evaluation and management of children and adolescents with overweight and obesity sparked debate in the medical community and the press.CrossRefPubMed •• Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060640. https://​doi.​org/​10.​1542/​peds.​2022-060640. The first edition of the American Academy of Pediatrics clinical practice guideline for evaluation and management of children and adolescents with overweight and obesity sparked debate in the medical community and the press.CrossRefPubMed
4.
go back to reference Simmonds M, Llewellyn A, Owen CG, Woolacott N. Obesity reviews. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. 2016. Simmonds M, Llewellyn A, Owen CG, Woolacott N. Obesity reviews. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. 2016.
5.
go back to reference •• Chung ST, Krenek A, Magge SN. Childhood obesity and cardiovascular disease risk. Curr Atheroscler Rep. 2023;25:405–15. https://doi.org/10.1007/s11883-023-01111-4. The global burden of pediatric obesity continues to rise and is associated with accelerated and early vascular aging especially in youth with obesity and type 2 diabetes.CrossRefPubMed •• Chung ST, Krenek A, Magge SN. Childhood obesity and cardiovascular disease risk. Curr Atheroscler Rep. 2023;25:405–15. https://​doi.​org/​10.​1007/​s11883-023-01111-4. The global burden of pediatric obesity continues to rise and is associated with accelerated and early vascular aging especially in youth with obesity and type 2 diabetes.CrossRefPubMed
11.
go back to reference Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Pub Health. 2017;4. Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Pub Health. 2017;4.
15.
go back to reference Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, Chung ST, Costa E, Courville A, Darcey V, Fletcher LA, Forde CG, Gharib AM, Guo J, Howard R, Joseph PV, McGehee S, Ouwerkerk R, Raisinger K, Rozga I, Stagliano M, Walter M, Walter PJ, Yang S, Zhou M. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 2019;30(1):67–77.e3. https://doi.org/10.1016/j.cmet.2019.05.008. Epub 2019 May 16. Erratum in: Cell Metab. 2019 Jul 2;30(1):226. Erratum in: Cell Metab. 2020 Oct 6;32(4):690. PMID: 31105044; PMCID: PMC7946062. Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, Chung ST, Costa E, Courville A, Darcey V, Fletcher LA, Forde CG, Gharib AM, Guo J, Howard R, Joseph PV, McGehee S, Ouwerkerk R, Raisinger K, Rozga I, Stagliano M, Walter M, Walter PJ, Yang S, Zhou M. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 2019;30(1):67–77.e3. https://​doi.​org/​10.​1016/​j.​cmet.​2019.​05.​008. Epub 2019 May 16. Erratum in: Cell Metab. 2019 Jul 2;30(1):226. Erratum in: Cell Metab. 2020 Oct 6;32(4):690. PMID: 31105044; PMCID: PMC7946062.
22.
go back to reference •• Mente A, Dehghan M, Rangarajan S, O’Donnell M, Hu W, Dagenais G, et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur Heart J. 2023;44(28):2560–79. https://doi.org/10.1093/eurheartj/ehad269. A diet comprised of higher amounts of fruit, vegetables, nuts, legumes, fish, and whole-fat dairy is associated with lower CVD and mortality in all world regions, especially in countries with lower income where consumption of these foods is low.CrossRefPubMedPubMedCentral •• Mente A, Dehghan M, Rangarajan S, O’Donnell M, Hu W, Dagenais G, et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur Heart J. 2023;44(28):2560–79. https://​doi.​org/​10.​1093/​eurheartj/​ehad269. A diet comprised of higher amounts of fruit, vegetables, nuts, legumes, fish, and whole-fat dairy is associated with lower CVD and mortality in all world regions, especially in countries with lower income where consumption of these foods is low.CrossRefPubMedPubMedCentral
25.
go back to reference Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322–34. https://doi.org/10.1172/JCI37385. Epub 2009 Apr 20. PMID: 19381015; PMCID: PMC2673878.CrossRefPubMedPubMedCentral Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322–34. https://​doi.​org/​10.​1172/​JCI37385. Epub 2009 Apr 20. PMID: 19381015; PMCID: PMC2673878.CrossRefPubMedPubMedCentral
26.
go back to reference Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology. 2017;153(3):743–52. https://doi.org/10.1053/j.gastro.2017.05.043. Epub 2017 Jun 1. PMID: 28579536; PMCID: PMC5813289.CrossRefPubMed Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology. 2017;153(3):743–52. https://​doi.​org/​10.​1053/​j.​gastro.​2017.​05.​043. Epub 2017 Jun 1. PMID: 28579536; PMCID: PMC5813289.CrossRefPubMed
30.
go back to reference Johnson RJ, et al. Perspective: a historical and scientific perspective of sugar and its relation with obesity and diabetes. Adv Nut. 2017;8.3:412–22.CrossRef Johnson RJ, et al. Perspective: a historical and scientific perspective of sugar and its relation with obesity and diabetes. Adv Nut. 2017;8.3:412–22.CrossRef
33.
go back to reference •• Wang L, Martínez Steele E, Du M, Pomeranz JL, O’Connor LE, Herrick KA, Luo H, Zhang X, Mozaffarian D, Zhang FF. Trends in consumption of ultraprocessed foods among US youths aged 2–19 Years, 1999–2018. JAMA. 2021;326(6):519–30. https://doi.org/10.1001/jama.2021.10238. Based on the NHANES cycles from 1999 to 2018, the estimated proportion of energy intake from consumption of ultraprocessed foods has increased among youths in the US and has consistently comprised the majority of their total energy intake.CrossRefPubMedPubMedCentral •• Wang L, Martínez Steele E, Du M, Pomeranz JL, O’Connor LE, Herrick KA, Luo H, Zhang X, Mozaffarian D, Zhang FF. Trends in consumption of ultraprocessed foods among US youths aged 2–19 Years, 1999–2018. JAMA. 2021;326(6):519–30. https://​doi.​org/​10.​1001/​jama.​2021.​10238. Based on the NHANES cycles from 1999 to 2018, the estimated proportion of energy intake from consumption of ultraprocessed foods has increased among youths in the US and has consistently comprised the majority of their total energy intake.CrossRefPubMedPubMedCentral
37.
go back to reference Rogovik AL, Goldman RD. Pharmacologic treatment of pediatric obesity. Can Fam Physician. 2011;57(2):195–7. PMID: 21642717; PMCID: PMC3038814.PubMedPubMedCentral Rogovik AL, Goldman RD. Pharmacologic treatment of pediatric obesity. Can Fam Physician. 2011;57(2):195–7. PMID: 21642717; PMCID: PMC3038814.PubMedPubMedCentral
38.
go back to reference Ludwig DS, Willett WC, Volek JS, Neuhouser ML. Dietary fat: from foe to friend? Science. 2018;362(6416):764–70.CrossRefPubMed Ludwig DS, Willett WC, Volek JS, Neuhouser ML. Dietary fat: from foe to friend? Science. 2018;362(6416):764–70.CrossRefPubMed
44.
go back to reference •• Xanthakos SA, Khoury JC, Inge TH, Jenkins TM, Modi AC, Michalsky MP, Chen MK, Courcoulas AP, Harmon CM, Brandt ML, Helmrath MA, Kalkwarf HJ. Teen Longitudinal Assessment of Bariatric Surgery Consortium. Nutritional risks in adolescents after bariatric surgery. Clin Gastroenterol Hepatol. 2020;18(5):1070–1081.e5. https://doi.org/10.1016/j.cgh.2019.10.048. In a prospective study of adolescents who underwent RYGB or VSG, the authors observed nutritional deficiencies by 5 y after the procedures-particularly in iron and B12 after RYGB.CrossRefPubMed •• Xanthakos SA, Khoury JC, Inge TH, Jenkins TM, Modi AC, Michalsky MP, Chen MK, Courcoulas AP, Harmon CM, Brandt ML, Helmrath MA, Kalkwarf HJ. Teen Longitudinal Assessment of Bariatric Surgery Consortium. Nutritional risks in adolescents after bariatric surgery. Clin Gastroenterol Hepatol. 2020;18(5):1070–1081.e5. https://​doi.​org/​10.​1016/​j.​cgh.​2019.​10.​048. In a prospective study of adolescents who underwent RYGB or VSG, the authors observed nutritional deficiencies by 5 y after the procedures-particularly in iron and B12 after RYGB.CrossRefPubMed
47.
go back to reference •• Paoli A, Bianco A, Moro T, Mota JF, Coelho-Ravagnani CF. The effects of ketogenic diet on insulin sensitivity and weight loss, which came first: the chicken or the egg? Nutrients. 2023;15(14):3120. https://doi.org/10.3390/nu15143120. In this review, the authors discuss the scientific evidence on the direct and weight loss mediated effects of KDs on glycemic status in humans, describing the KD’s biochemical background and the underlying mechanisms.CrossRefPubMedPubMedCentral •• Paoli A, Bianco A, Moro T, Mota JF, Coelho-Ravagnani CF. The effects of ketogenic diet on insulin sensitivity and weight loss, which came first: the chicken or the egg? Nutrients. 2023;15(14):3120. https://​doi.​org/​10.​3390/​nu15143120. In this review, the authors discuss the scientific evidence on the direct and weight loss mediated effects of KDs on glycemic status in humans, describing the KD’s biochemical background and the underlying mechanisms.CrossRefPubMedPubMedCentral
48.
go back to reference •• Parcha V, Heindl B, Kalra R, Li P, Gower B, Arora G, Arora P. Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults: insights from NHANES. J Clin Endocrinol Metab. 2022;107(1):e25–37. https://doi.org/10.1210/clinem/dgab645. PMID: 34473288; PMCID: PMC8684535. Four-in-10 young American adults have IR, which occurs in a cluster with cardiometabolic risk factors. Nearly half of young adults with IR are nonobese. Screening efforts for IR irrespective of BMI may be required.CrossRefPubMed •• Parcha V, Heindl B, Kalra R, Li P, Gower B, Arora G, Arora P. Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults: insights from NHANES. J Clin Endocrinol Metab. 2022;107(1):e25–37. https://​doi.​org/​10.​1210/​clinem/​dgab645. PMID: 34473288; PMCID: PMC8684535. Four-in-10 young American adults have IR, which occurs in a cluster with cardiometabolic risk factors. Nearly half of young adults with IR are nonobese. Screening efforts for IR irrespective of BMI may be required.CrossRefPubMed
50.
go back to reference •• Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(5):525–38. https://doi.org/10.1016/j.jacc.2019.11.044. PMID: 32029136; PMCID: PMC7187687. A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a basis for early and sustainable, evidence-based therapeutic targeting to promote cardiometabolic health and mitigate the development and ravages of cardiovascular disease.CrossRefPubMedPubMedCentral •• Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(5):525–38. https://​doi.​org/​10.​1016/​j.​jacc.​2019.​11.​044. PMID: 32029136; PMCID: PMC7187687. A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a basis for early and sustainable, evidence-based therapeutic targeting to promote cardiometabolic health and mitigate the development and ravages of cardiovascular disease.CrossRefPubMedPubMedCentral
55.
go back to reference Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S. Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care. 2019;42(2):265–72. https://doi.org/10.2337/dc18-1178. Epub 2018 Nov 19. PMID: 30455334; PMCID: PMC6341282.CrossRefPubMed Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S. Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care. 2019;42(2):265–72. https://​doi.​org/​10.​2337/​dc18-1178. Epub 2018 Nov 19. PMID: 30455334; PMCID: PMC6341282.CrossRefPubMed
56.
go back to reference Jago R, Drews KL, Otvos JD, Willi SM, Buse JB. Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study. Int J Obes (London). 2016;40(7):1157–63. https://doi.org/10.1038/ijo.2016.84. Epub 2016 May 4. PMID: 27143035; PMCID: PMC4935612.CrossRef Jago R, Drews KL, Otvos JD, Willi SM, Buse JB. Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study. Int J Obes (London). 2016;40(7):1157–63. https://​doi.​org/​10.​1038/​ijo.​2016.​84. Epub 2016 May 4. PMID: 27143035; PMCID: PMC4935612.CrossRef
58.
go back to reference •• Perry BI, Stochl J, Upthegrove R, et al. Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiat. 2021;78(4):416–25. https://doi.org/10.1001/jamapsychiatry.2020.4180. The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis.CrossRef •• Perry BI, Stochl J, Upthegrove R, et al. Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiat. 2021;78(4):416–25. https://​doi.​org/​10.​1001/​jamapsychiatry.​2020.​4180. The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis.CrossRef
Metadata
Title
Beyond Obesity and Overweight: The Clinical Assessment and Treatment of Excess Body Fat in Children
Part 1 — Insulin Resistance as the Root Cause of Pediatric Obesity
Authors
Mark Cucuzzella
James Bailes
Jenny Favret
Nina Paddu
Anna Beth Bradley
Publication date
06-05-2024
Publisher
Springer US
Published in
Current Obesity Reports
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-024-00565-0
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.